eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | multiple myeloma |
| Comorbidity | C0022658|nephropathy |
| Sentences | 9 |
| PubMedID- 22363889 | nephropathy associated with multiple myeloma is usually due to abnormal light chains deposition. |
| PubMedID- 22880177 | In addition, there must be no evidence of hyperkalemia, anemia or nephropathy leading to myeloma in a hematologic study. |
| PubMedID- 26281203 | [the concurrence of light-chain deposition disease, al-amyloidosis, and cast nephropathy in a patient with multiple myeloma]. |
| PubMedID- 22533933 | [improved prognosis in light chain nephropathy due to multiple myeloma]. |
| PubMedID- 21512075 | Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced ct. |
| PubMedID- 21894755 | A rare variant of nephropathy in multiple myeloma (mm) is reported. |
| PubMedID- 23591252 | Lambda light chain myeloma with oliguric cast nephropathy and remission with bortezomib, doxorubicin and dexamethasone. |
| PubMedID- 20827195 | Management options for cast nephropathy in multiple myeloma. |
| PubMedID- 20671999 | Current therapy for cast nephropathy involves treatment of the underlying myeloma with or without plasmapheresis, which can often lead to reversal of cast nephropathy if therapy is instituted early [13]. |
Page: 1